The first human trial of COVID-19 vaccine Nanocovax begins in Vietnam on December 17 with the first three volunteers, receiving injections at the Military Medical Academy. (Photo: VNA) Hanoi (VNA) – The trials of COVID-19 vaccine inVietnam strictly follow the guidance of the World Health Organisation (WHO) andinternational organisations in terms of safety and immunity, said Foreign Ministry’sSpokesperson Le Thi Thu Hang at a press conference in Hanoi on January 14.
She said that the Military Medical University gave 75mcg ofNanocovax, a COVID-19 vaccine developed by Vietnam, to three volunteerson January 12. This is the highest dose of the vaccine given to volunteersduring the first stage of human trials.
Nanocovax is developed by the NanogenPharmaceutical Biotechnology JSC, basing on recombinant protein technology. Currently, there has been no evidence that new COVID-19 variants can resistthis technology./.